Effects of berberine, evodiamine and indirubin on gastric cancer cell

World Chinese Journal of Digestology

Volumn 13, Issue 4, 2005, Pages 472-476

  Tan, Yu Hui ^a   Chen, Wei Wen ^a   Wu, Ying Ya ^a   Chen, Guan Lin ^a   Li, Ru Liu ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Berberine; Evodiamine; Gastric cancer; Indirubin

Indexed keywords

BERBERINE; DNA FRAGMENT; DOXORUBICIN; EVODIA FRUIT; EVODIAMINE; INDIRUBIN; METHYL GREEN; PYRONINE;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CHINESE MEDICINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COPTIS; DIPLOIDY; DNA DEGRADATION; DOSE TIME EFFECT RELATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; STAINING; STATISTICAL SIGNIFICANCE; STOMACH CANCER;

EID: 20444436317     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v13.i4.472     Document Type: Article

References (31)

1. Xiao Z, Hao Y, Liu B, Qian L. Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China. Leuk Lymphoma 2002;43:1763-1768
2. Knockaert M, Blondel M, Bach S, Leost M, Elbi C, Hager GL, Nagy SR, Han D, Denison M, Ffrench M, Ryan XP, Magiatis P, Polychronopoulos P, Greengard P, Skaltsounis L, Meijer L. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene 2004;23:4400-4412
3. Kuo CL, Chou CC, Yung BY. Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett 1995;93:193-200
4. Wang DY, Yeh CC, Lee JH, Hung CF, Chung JG. Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH)and brain glioblastoma multiforms (GBM 8401)cells. Neurochem Res 2002;27:883-889
5. Lin S, Tsai SC, Lee CC, Wang BW, Liou JY, Shyu KG. Berberine inhibits HIF-1alpha expression via enhanced proteolysis. Mol Pharmacol 2004;66:612-619
6. Lin CC, Ng LT, Hsu FF, Shieh DE, Chiang LC. Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin)on hepatoma and leukaemia cell growth. Clin Exp Pharmacol Physiol 2004;31:65-69
7. Colombo ML, Bugatti C, Mossa A, Pescalli N, Piazzoni L, Pezzoni G, Menta E, Spinelli S, Johnson F, Gupta RC, Dasaradhi L. Cytotoxicity evaluation of natural coptisine and synthesis of coptisine from berberine. Farmaco 2001;56:403-409
8. Kang MR, Chung IK. Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine. Mol Pharmacol 2002; 61:879-884
9. Li XK, Motwani M, Tong W, Bornmann W, Schwartz GK. Huanglian, A Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol Pharmacol 2000;58:1287-1293
10. Iizuka N, Oka M, Yamamoto K, Tangoku A, Miyamoto K, Miyamoto T, Uchimura S, Hamamoto Y, Okita K. Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray. Int J Cancer 2003;107:666-672
11. Mitani N, Murakami K, Yamaura T, Ikeda T, Saiki I. Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma. Cancer Lett 2001;165:35-42
12. Jagetia GC, Baliga MS. Effect of Alstonia scholaris in enhancing the anticancer activity of berberine in the Ehrlich ascites carcinoma-bearing mice. J Med Food 2004;7:235-244
13. Anis KV, Rajeshkumar NV, Kuttan R. Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol 2001;53:763-768
14. Zhang Y, Zhang QH, Wu LJ, Tashiro S, Onodera S, Ikejima T. Atypical apoptosis in L929 cells induced by evodiamine isolated from Evodia rutaecarpa. J Asian Nat Prod Res 2004;6:19-27
15. Zhang Y, Wu LJ, Tashiro S, Onodera S, Ikejima T. Intracellular regulation of evodiamine-induced A375-S2 cell death. Biol Pharm Bull 2003;26:1543-1547
16. Zhang Y, Wu LJ, Tashiro S, Onodera S, Ikejima T. Evodiamine induces tumor cell death through different pathways: apoptosis and necrosis. Acta Pharmacol Sin 2004;25:83-89
17. Ogasawara M, Matsubara T, Suzuki H. Screening of natural compounds for inhibitory activity on colon cancer cell migration. Biol Pharm Bull 2001;24:720-703
18. Ogasawara M, Matsubara T, Suzuki H. Inhibitory effects of evodiamine on in vitro invasion and experimental lung metastasis of murine colon cancer cells. Biol Pharm Bull 2001;24:917-920
19. Ogasawara M, Suzuki H. Inhibition by evodiamine of hepatocyte growth factor-induced invasion and migration of tumor cells. Biol Pharm Bull 2004;27:578-582
20. Ogasawara M, Matsunaga T, Takahashi S, Saiki I, Suzuki H. Anti-invasive and metastatic activities of evodiamine. Biol Pharm Bull 2002;25:1491-1493
21. Fei XF, Wang BX, Li TJ, Tashiro S, Minami M, Xing de J, Ikejima T. Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells. Cancer Sci 2003; 94:92-98
22. Kan SF, Huang WJ, Lin LC, Wang PS. Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Int J Cancer 2004;110:641-651